tanshinone has been researched along with Chronic Kidney Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, L; Fu, X; Huang, B; Lin, F; Lin, Y; Yang, J | 1 |
Cheng, X; Huang, RH; Lin, X; Wang, DT; Yang, YJ; Zhang, ZH | 1 |
Ahn, SY; Ahn, YM; Chung, JH; Kang, SW; Kim, SD; Kim, SK; Lee, BC; Lee, SH | 1 |
3 other study(ies) available for tanshinone and Chronic Kidney Diseases
Article | Year |
---|---|
Effects of tanshinone IIA on the regulation of renal proximal tubular fibrosis.
Topics: Abietanes; Actins; Cadherins; Cell Line; Epithelial Cells; Fibronectins; Fibrosis; Humans; Kidney Tubules, Proximal; Renal Insufficiency, Chronic; RNA, Messenger; Snail Family Transcription Factors; Vimentin | 2017 |
Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Topics: Abietanes; Animals; Blotting, Western; Disease Models, Animal; Drugs, Chinese Herbal; Fibrosis; Gene Expression; Immunohistochemistry; Kidney; Kidney Function Tests; Male; Medicine, Chinese Traditional; Nephrectomy; NF-kappa B; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Renal Insufficiency, Chronic; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2015 |
Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease.
Topics: Abietanes; Administration, Oral; Angiotensin II; Animals; Collagen Type IV; Creatinine; Disease Models, Animal; Drugs, Chinese Herbal; Kidney; Male; Phenanthrenes; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Salvia miltiorrhiza; Transforming Growth Factor beta1 | 2010 |